Monroe Dispatch - No Struggle, No Progress

Participants are now being accepted to be part of a national COVID-19 vaccine clinical trial coordinated in our area through Monroe-based Clinical Trials of America (CTA). Pharmaceutical company AstraZeneca is conducting the trials beginning this month while over 30,000 have participated in Phase III thus far. CTA CEO Jeb Andrews, PhD, states that they are honored to have been selected to secure the 1,500 participants in northeast Louisiana, and that two-thirds of the participants will receive the live vaccine while the remaining receive a placebo. Dr. Andrews noted that typically trials li...